RecruitingNCT04166266
National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
Sponsor
ANRS, Emerging Infectious Diseases
Enrollment
800 participants
Start Date
Feb 19, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This is a multicentre observational study with prospective and retrospective data collection and retrospective data collection and biological collection from patients with HBV/HDV co-infection.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age > 18 years,
- Presenting a chronic HDV infection (positive serology),
- Who gave his written informed consent before any intervention and the day of inclusion at the latest,
- Affiliated to Health Insurance or to the "Aide Médicale d'Etat" (request for exemption pending).
Exclusion Criteria3
- Patient participating in another biomedical research with an exclusion period ongoing at inclusion,
- Vulnerable patient (minor, adults legally protected: under judicial protection, guardianship, or supervision, persons deprived of their liberty).
- Patients with predictable difficulties of follow-up according to the investigator.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERBlood draw for the laboratory assessment
Blood sampling for the biobank and, in addition, as sub-studies are planned on sub-groups of patients, additional blood samples are planned for the patients in these sub-studies.
Locations(38)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04166266
Related Trials
Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]
NCT062164701 location
Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients
NCT051824631 location
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
NCT045971641 location
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
NCT065506221 location
A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
NCT065259095 locations